Senzime AB Namn-Aktier AK o.N.
- BID
0.317
- ASK
0.3875
- 3,200 Units0 Units
- 07/21, 20:13:19 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
36.55%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.08 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.317 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 08:02:18 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.321 | 0.298 |
| PREV. DAY'S PRICE | 0.316 | (07/20) |
| CHANGE DAY BEFORE | +0.00 | 0.32 % |
| 52 WEEK HIGH / LOW | 0.7 (07/28) | 0.3015 (07/20) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.13 | -0.08 | -0.08 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | - | - |
PRICE - BOOK RATIO | 2.37 | 2.12 | 2.79 | - | - |
PRICE - SALES RATIO | 19.17 | 11.50 | 7.63 | - | - |
PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A0X93V |
| ISIN | SE0002478776 |
| SYMBOL | 6YC |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | SENZIME AB AK |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -7.60 % | -14.36 % | -41.04 % | -32.12 % | -36.55 % | -27.02 % | -86.01 % | -33.26 % |
| HIGH | 0.36 | 0.40 | 0.54 | 0.54 | 0.70 | 0.79 | 2.41 | 0.55 |
| LOW | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.23 | 0.30 |
Dividende
pro Aktie
SENZIME AB AK does not deliver dividend information
Company profile
Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. It manufactures products for automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patient's neuromuscular function perioperatively and in the intensive care medicine setting. The company also distributes bioreactor systems for the pharmaceutical industry. Senzime was founded by Thomas Ambjorn Carlsson in 1999 and is headquartered in Uppsala, Sweden.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.